Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients

Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their h...

Descripción completa

Detalles Bibliográficos
Autores principales: Efrati, Shai, Catalogna, Merav, Abu Hamed, Ramzia, Hadanny, Amir, Bar-Chaim, Adina, Benveniste-Levkovitz, Patricia, Strugo, Refael, Levtzion-korach, Osnat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253728/
https://www.ncbi.nlm.nih.gov/pubmed/34215811
http://dx.doi.org/10.1038/s41598-021-93175-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253728/
https://www.ncbi.nlm.nih.gov/pubmed/34215811
http://dx.doi.org/10.1038/s41598-021-93175-y

Ejemplares similares